Sitagliptin and Fractures in Type 2 Diabetes: A Nationwide Population-Based Propensity-Matching Study

• Hauptverfasser: Shih-Yi Lin (Verfasst von), Wu-Huei Hsu (Verfasst von), Cheng-Chieh Lin (Verfasst von), Cheng-Li Lin (Verfasst von), Chun-Hao Tsai (Verfasst von), Hung-Chieh Yeh (Verfasst von), Chung-Y. Hsu (Verfasst von), Chia-Hung Kao (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2018-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Sitagliptin, a dipeptidyl peptidase-4 inhibitor possibly affects bone turnover. We conducted this cohort study to determine whether sitagliptin is associated with an increased risk of fracture.Methods: The sitagliptin cohort included 1,578 patients aged 20 years and above. The nonsitagli...